Meeting
2019 Gastrointestinal Cancers Symposium
Outcomes following stereotactic body radiotherapy (SBRT) in locally recurrent rectal cancer (LRRC) in a previously irradiated pelvis.
Authors
Thomas Smith
Mount Vernon Cancer Centre, Northwood, United Kingdom
Thomas Smith , Sean O'Cathail , Yatman Tsang , Mark Harrison , Maria A Hawkins
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 640)
DOI
10.1200/JCO.2019.37.4_suppl.640
Abstract #
640
Poster Bd #
L5
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
PROSTOX, a signature of late GU toxicity after SBRT radiotherapy in MIRAGE, a prospective trial.
First Author: Amar Upadhyaya Kishan
Poster
2024 ASCO Genitourinary Cancers Symposium
Pretreatment colonoscopy impact on acute gastrointestinal (GI) toxicity following curative stereotactic body radiation therapy (SBRT) for localized prostate cancer.
First Author: Jonathan W. Lischalk
Poster
2024 ASCO Genitourinary Cancers Symposium
Long-term treatment outcomes from the International Multi-Institutional Stereotactic Body Radiation Therapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium.
First Author: Luca Faustino Valle
Poster
2024 ASCO Gastrointestinal Cancers Symposium
A single-institution experience of acute toxicities in patients treated with short course hypofractionated radiotherapy in locally advanced rectal cancer.
First Author: Katie Nadine Lee